Identifiers
Database identifiers and provenance.
- Ligand ID
MTE- PDB
1fiq- UniProt (similar protein)
P80457- Target protein
- PA1523
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 395.4
- LogP ≤ 5 -0.54
- H-bond donors ≤ 5 8
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 171.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C([C@@H]1C(=C([C@H]2[C@@H](O1)NC3=C(N2)C(=O)NC(=N3)N)S)S)OP(=O)(O)OC([C@@H]1C(=C([C@H]2[C@@H](O1)NC3=C(N2)C(=O)NC(=N3)N)S)S)OP(=O)(O)O
InChI=1S/C10H14N5O6PS2/c11-10-14-7-4(8(16)15-10)12-3-6(24)5(23)2(21-9(3)13-7)1-20-22(17,18)19/h2-3,9,12,23-24H,1H2,(H2,17,18,19)(H4,11,13,14,15,16)/t2-,3+,9-/m1/s1InChI=1S/C10H14N5O6PS2/c11-10-14-7-4(8(16)15-10)12-3-6(24)5(23)2(21-9(3)13-7)1-20-22(17,18)19/h2-3,9,12,23-24H,1H2,(H2,17,18,19)(H4,11,13,14,15,16)/t2-,3+,9-/m1/s1
HPEUEJRPDGMIMY-IFQPEPLCSA-NHPEUEJRPDGMIMY-IFQPEPLCSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01799' 'PF02738' 'PF20256
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand MTE →
- PDB RCSB structure 1fiq →
- UniProt UniProt P80457 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “MTE”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1523.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).